Skip to Search
Skip to Main Content
Skip to Footer
Google Translate
Select language
English
French
German
Italian
Portuguese
Spanish
User Login
Username
*
Password
*
Administration Login
×
Google Translate
Select language
English
French
German
Italian
Portuguese
Spanish
RESEARCH
Powered by EBSCO
Menu
Site Search
Search Options
Curated Discovery
More Research
Publication Finder
Google Scholar
All
COVID-19 Related Subjects Only
Back to COVID-19 Information Portal
Open Access Resources
RSS Feed
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Health Effects of Involuntary Displacement of Homeless Individuals Who Inject Drugs
Study Provides New Insight Into Female Sex Hormones and Migraines
FDA Warns Consumers to Not Purchase or Use Nose Slap and Soul Slap Products Marketed for Alertness and Energy Boosting
FDA Warns Consumers to Not Purchase or Use Nose Slap and Soul Slap Products Marketed for Alertness and Energy Boosting
FDA Warns Consumers to Not Purchase or Use Nose Slap and Soul Slap Products Marketed for Alertness and Energy Boosting
FDA Warns Consumers to Not Purchase or Use Nose Slap and Soul Slap Products Marketed for Alertness and Energy Boosting
FDA Warns Consumers to Not Purchase or Use Nose Slap and Soul Slap Products Marketed for Alertness and Energy Boosting
FDA Warns Consumers to Not Purchase or Use Nose Slap and Soul Slap Products Marketed for Alertness and Energy Boosting
FDA Approves Lumryz (sodium oxybate) for Cataplexy or Excessive Daytime Sleepiness in Adults with Narcolepsy
FDA Approves Lumryz (sodium oxybate) for Cataplexy or Excessive Daytime Sleepiness in Adults with Narcolepsy
Pages
« first
‹ previous
…
2
3
4
5
6
7
8
9
10
next ›
last »
×